Advocacy organizations: Stop threatening health care workers who speak out about lack of PPE

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

In a public letter to the American Hospital Association, 54 health care organizations condemned attempts by hospital administrators to muzzle health care workers who speak out against coronavirus caseloads and supply shortages.

The letter, dated March 27, follows:

“We were appalled to read recent media reports about hospital administrators across the U.S. muzzling doctors, nurses, and other healthcare professionals with threats of disciplinary action for speaking out about coronavirus patient caseloads and dwindling hospital supplies needed to care for such patients.

“It is critical that the public and local, state, and federal government officials fully comprehend the scope of shortages of personal protective equipment, mechanical ventilators, intensive care unit beds, and other medical supplies so that appropriate steps can be taken to mitigate shortages of these essential medical resources, appropriately and fairly allocate limited resources, and thus protect the safety and welfare of health care workers and patients alike. Attempts to cover up these shortages by muzzling health care workers who are on the front lines of fighting the COVID-19 pandemic are reprehensible and reckless and endanger public health.

“Although such actions may be commonplace in countries with authoritarian regimes, they are not acceptable in the U.S. The undersigned consumer advocacy, workers’ rights, science, research, public health, civil rights, human rights, and grassroots political organizations, labor unions, and individuals therefore demand that the American Hospital Association publicly denounce any such efforts to muzzle health care professionals and call on its member hospitals and health care systems to encourage their doctors, nurses, and other health care professionals to speak freely about coronavirus patient caseloads, dwindling hospital supplies, and any other challenges that should be immediately addressed.

“Thank you for your prompt attention to this urgent public health matter. Please contact Dr. Michael Carome, Director of Public Citizen’s Health Research Group, at mcarome@citizen.org with your response.”

Table of Contents

YOU MAY BE INTERESTED IN

When our hematological malignancy testing pilot project began in Eldoret, Kenya, there seemed to be a mismatch in relation to progress in healthcare. The region, like much of sub-Saharan Africa, had been focusing on combatting infectious diseases such as HIV and malaria—which was much-needed—yet cancer care was under-resourced. 
Artificial intelligence is rapidly transforming biomedical research and healthcare. Large language models, foundation models, and AI agents are increasingly being deployed to assist with data interpretation, literature review, clinical decision support, and translational research. 
In modern oncology, important insights from clinical trials often emerge years after initial publication. As new therapies extend survival and transition more patients into long-term remissions, clinicians and researchers are increasingly looking beyond initial response rates to understand durability, long-term safety, and even the possibility of a cure. 

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login